ChinaBiotech

Novo Holdings Eyes Expansion into China's Booming Biotech Sector

2 months ago

In a bold move aimed at capitalizing on the growing opportunities within China's biotechnology landscape, Novo Holdings has revealed its intentions to deepen its investment footprint in the region. The announcement comes during a significant period for the global biotech industry, as innovations in healthcare continue to accelerate, particularly in response to pressing medical needs.

Chinese Competitors Leverage Illumina's Blacklisting to Attract Clients

4 months ago

In a significant development within the biotechnology sector, Chinese rivals are strategically capitalizing on the recent blacklisting of Illumina, a leading player in the genomics industry. This move has opened the door for these competitors to enhance their market presence and appeal to potential clients who are currently reevaluating their partnerships and technology sourcing.